Noile-Immune Biotech (TSE:4893) Change In Inventory : 円0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Change In Inventory?

Noile-Immune Biotech's change in inventory for the quarter that ended in Mar. 2024 was 円0.0 Mil. It means Noile-Immune Biotech's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Noile-Immune Biotech's change in inventory for the fiscal year that ended in Dec. 2023 was 円-17.0 Mil. It means Noile-Immune Biotech's inventory increased by 円17.0 Mil from Dec. 2022 to Dec. 2023 .

Noile-Immune Biotech's Total Inventories for the quarter that ended in Mar. 2024 was 円16.6 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Noile-Immune Biotech's Days Inventory for the quarter that ended in Mar. 2024 was 8,769.59.

Inventory Turnover measures how fast the company turns over its inventory within a year. Noile-Immune Biotech's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Noile-Immune Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 7.24.

Noile-Immune Biotech Change In Inventory Historical Data

The historical data trend for Noile-Immune Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Change In Inventory Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Inventory

-10.02

7.12

0.34

-16.98

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial				-	-	-	-	-

Noile-Immune Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

Noile-Immune Biotech (TSE:4893) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Noile-Immune Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	18.7405	/	0.195	*	365 / 4
	=	8,769.59

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Noile-Immune Biotech's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.195	/	18.7405
	=	0.01

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Noile-Immune Biotech's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	18.7405	/	2.587
	=	7.24

Noile-Immune Biotech Change In Inventory Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines